Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

Acne Vulgaris and Rosacea Clinical Trial

Official title:

Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00483145
• Other study ID #: KF-01-328309
• Status: Completed
• Phase: N/A
• First received: June 4, 2007
• Last updated: June 2, 2008
• Start date: November 2006
• Est. completion date: November 2007

Study information

• Verified date: June 2008
• Source: Bispebjerg Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: November 2007
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Inflammatory acne and rosacea

• Skin types I-IV

Exclusion Criteria:

• Patients younger than 18 years

• Skin types V and VI

• Topical and systemic conventional acne treatments

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind

Related Conditions & MeSH terms

• Acne Vulgaris
• Acne Vulgaris and Rosacea
• Rosacea

Intervention

Device:
• Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)

• Long-pulsed dye laser

• Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

Locations

Country	Name	City	State
Denmark	Bispebjerg Hospital	Copenhagen NV

Sponsors (1)

Lead Sponsor	Collaborator
Bispebjerg Hospital

Country where clinical trial is conducted

Denmark,